1. Home
  2. JF vs SCNX Comparison

JF vs SCNX Comparison

Compare JF & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

JF

J and Friends Holdings Limited American Depositary Shares

HOLD

Current Price

$0.91

Market Cap

17.8M

Sector

N/A

ML Signal

HOLD

Logo Scienture Holdings Inc.

SCNX

Scienture Holdings Inc.

HOLD

Current Price

$0.26

Market Cap

16.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JF
SCNX
Founded
2012
2010
Country
China
United States
Employees
30
N/A
Industry
Other Pharmaceuticals
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.8M
16.2M
IPO Year
2017
2019

Fundamental Metrics

Financial Performance
Metric
JF
SCNX
Price
$0.91
$0.26
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
★ $1.50
AVG Volume (30 Days)
7.8K
★ 622.6K
Earning Date
04-24-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $3,831,778.00
Revenue This Year
N/A
$1,097.38
Revenue Next Year
N/A
$239.80
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 30.72
52 Week Low
$0.81
$0.24
52 Week High
$1.19
$2.60

Technical Indicators

Market Signals
Indicator
JF
SCNX
Relative Strength Index (RSI) 38.44 20.94
Support Level $0.90 $0.24
Resistance Level $1.03 $0.43
Average True Range (ATR) 0.05 0.02
MACD -0.01 -0.01
Stochastic Oscillator 0.00 4.64

Price Performance

Historical Comparison
JF
SCNX

About JF J and Friends Holdings Limited American Depositary Shares

J and Friends Holdings Ltd providing merchant digitalization and commerce-enablement solutions to small and medium enterprises (SME). Its solutions feature critical functionality that SMEs need to engage with consumers, manage their operations, accept payments, and grow their business. Such solutions empower single- and multi-location retailers, restaurants, and other SMEs to compete successfully in an omni-channel market environment by engaging with consumers across online, mobile, and physical channels. The group conducts all of its current operations in Australia and generates revenues from continuing operations are derived from within Australia.

About SCNX Scienture Holdings Inc.

Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on the commercialization and development of products for the treatment of cardiovascular (CVS) and Central Nervous System (CNS) diseases. Scienture LLC launched its first commercial product for hypertension and is in the process of commercializing its second product for the treatment of opioid overdose. Its development pipeline consists of a broad range of novel product candidates including new potential treatments for migraine, thrombosis, pain and other related disorders.

Share on Social Networks: